Cleo kicks off long path towards FDA approval for ovarian cancer blood tests
Still a relatively recent arrival to the bourse, Cleo Diagnostics (ASX:COV) has…
Cleo Diagnostics Ltd (ASX:COV)
About Cleo Diagnostics Ltd
Key Information
COV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 24/07/2024 | Price Sensitive PS Quarterly activities and cashflow report | 732.66KB | 462 |
| 26/06/2024 | Price Sensitive PS Cleo Commences US Regulatory Process with FDA | 2.75MB | 5.4K |
| 24/06/2024 | Application for quotation of securities - COV | 14.19KB | 231 |
| 14/06/2024 | Restricted securities to be released from escrow | 329.6KB | 1.1K |
| 29/05/2024 | Price Sensitive PS COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark | 2.8MB | 21K |
| 29/04/2024 | Price Sensitive PS Quarterly activities and cashflow report | 4.39MB | 524 |
| 11/04/2024 | Price Sensitive PS COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials | 2.78MB | 892 |
| 02/04/2024 | Price Sensitive PS CLEO Appoints Partner to Commence U.S. Market Access Program | 2.79MB | 1.1K |